This study will determine the efficacy of oral risperidone (Risperdal) versus long-acting
injectable paliperidone palmitate (Invega Sustenna) in treating people with first-episode
Drug: paliperidone palmitate
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01451736
Ages eligible for Study
18 Years to 45 Years
Genders eligible for Study
Accepts Healthy Volunteers
A first episode of a psychotic illness is occurring or did occur within the last 2 years;
A diagnosis by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition(DSM-IV)of schizophrenia, schizoaffective disorder, depressed type, or schizophreniform disorder; and
Between 18 and 45 years of age.
Neurological disorder (e.g., epilepsy) or significant head injury;
Significant alcohol or substance use disorder within the six months prior to the first episode and evidence that substance abuse triggered the psychotic episode or makes the schizophrenia diagnosis ambiguous;
Mental retardation, i.e. premorbid intelligence quotient (IQ) less than 70;
Insufficient acculturation and fluency in the English language to avoid invalidating research measures of thought, language, and speech disorder or of verbal abilities;
Residence likely to be outside of commuting distance of the University of California, Los Angeles (UCLA) Aftercare Research Program; or
Patient has shown an inadequate response to an adequate previous trial of oral or long-acting injectable risperidone, paliperidone, or paliperidone palmitate.
All locations for NCT01451736
United States (1)
UCLA Semel Institute for Neuroscience and Human Behavior
Los Angeles, California, United States, 90095
View full eligibility
Tris trial is registered with FDA with number: NCT01451736. The sponsor of the trial is University of California, Los Angeles and it is looking for 170 volunteers for the current phase.
Official trial title: Clinical and Cognitive Effects of Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.